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Prefrontal-accumbens opioid plasticity: 
Implications for relapse and dependence 
 
Matthew Hearing 
Department of Biomedical Sciences, Marquette University, Milwaukee, WI 
 
Abstract 
In addiction, an individual’s ability to inhibit drug seeking and drug taking is thought to reflect a pathological 
strengthening of drug-seeking behaviors or impairments in the capacity to control maladaptive behavior. These 
processes are not mutually exclusive and reflect drug-induced modifications within prefrontal cortical and 
nucleus accumbens circuits, however unlike psychostimulants such as cocaine, far less is known about the 
temporal, anatomical, and cellular dynamics of these changes. We discuss what is known regarding opioid-
induced adaptations in intrinsic membrane physiology and pre-/postsynaptic neurotransmission in principle 
pyramidal and medium spiny neurons in the medial prefrontal cortex and nucleus accumbens from 
electrophysiological studies and explore how circuit specific adaptations may contribute to unique facets 
of opioid addiction. 
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1. Introduction 
Opioid-based drugs are mainstays for clinical pain management, however the misuse of and addiction to 
opioids—including prescription pain relievers, heroin, and synthetic opioids such as fentanyl—is a serious 
national crisis that affects public health as well as social and economic welfare [[1], [2], [3]]. Increasing evidence 
suggest that neural circuit adaptations responsible for withdrawal that accompany dependence are not 
necessarily synonymous with those responsible for establishing drug seeking behavior, creation of relapse-
driving cue-/context associations and impaired control over drug intake – highlighting a need to better 
understand how specific aspects of opioid plasticity uniquely contribute to opioid abuse. The medial prefrontal 
cortex (mPFC) and nucleus accumbens (NAc) are two brain regions that are critically involved in reward, 
motivated behavior, and cognitive control where drugs of abuse are believed to promote pathological plasticity 
that leads to enduring behavioral abnormalities associated with addiction [[4], [5], [6], [7], [8], [9], [10]], 
however our understanding of this plasticity in relation to opioid abuse remains surprisingly absent. The purpose 
of this review is to discuss what is known and highlight important knowledge gaps regarding opioid-induced 
plasticity in the mPFC and NAc using primarily electrophysiology data from preclinical models, and explore 
potential relevance of this plasticity to unique facets of opioid addiction (e.g., reward, drug-seeking, and 
dependence). 
2. Medial prefrontal cortex 
Deep layer glutamatergic pyramidal neurons within the more dorsal prelimbic (PrL) and ventral infralimbic (IL) 
regions of the mPFC provide widespread glutamatergic input to cortical and subcortical structures 
[[11], [12], [13], [14]]. Differences in the anatomical connectivity of these regions contribute to their dissociable 
(often opposing) roles in regulating limbic and cognitive functions, thus regional adaptations may have distinct 
implications for drug-seeking behavior and impaired control of drug intake [5,10,[15], [16], [17], [18], [19], [20]]. 
In addition to anatomical connectivity, recent evidence indicates that these neurons can be further divided into 
subpopulations based on morphology, molecular and physiological profile – including the expression of D1- 
versus D2-type dopamine receptors – as well as what type of excitatory or inhibitory input they receive 
[[21], [22], [23], [24], [25], [26], [27]]. As these sub-populations likely provide an anatomical frame work to 
regulate complex behavioral control and define how they undergo experience-induced plasticity, a critical step 
towards understanding how addiction alters PFC networks will be to identify cell-type and pathway-specific 
adaptations [[26], [27], [28], [29]]. 
2.1. Opioid effects on mPFC pyramidal neuron activity 
Preclinical studies have indeed identified a role for mPFC glutamate input to regions such as the NAc and ventral 
tegmental area (VTA), as well as dopaminergic neurotransmission in the PFC in numerous facets of opioid 
addiction, including acute reward [[30], [31], [32], [33], [34], [35], [36], [37], [38]], relapse related drug seeking 
following abstinence and extinction [[39], [40], [41], [42], [43]], precipitated somatic withdrawal [44], and opioid 
addiction memory formation [45]. Studies examining the acute effects of opioids on pyramidal neuron activity 
are relatively few in number, however in vivo work indicates that morphine attenuates the excitatory response 
of pyramidal neurons to locally applied and afferent-evoked glutamate [31]. Notably, effects of morphine on 
transmitter release were more pronounced at mediodorsal thalamus afferents compared to input arising from 
the baslolateral amygdala (BLA) and hippocampus (HPC) -- highlighting the possibility of pathway- or cell-type 
specific regulation by mu opioid receptors [31,46]. Moreover, these findings are in apparent contrast to in vivo 
studies with other drug classes (e.g., cocaine, nicotine, ethanol) where acute exposure produced a transient 
depolarization and subsequent activation of mPFC layer 5/6 putative pyramidal neurons [[47], [48], [49], [50]]. 
Following more prolonged opioid exposure, reduced metabolic activity within frontal cortical regions of heroin 
addicts is thought to reflect impaired functionality that contributes reduced control over limiting drug intake 
[5,10,51] as well as affective withdrawal as it correlated with anhedonia in opioid dependent subjects [52]. 
Alternatively, drug “craving” in opioid users in response to viewing drug-associated cues is correlated with 
increased activation of frontal cortex regions [41,[53], [54], [55], [56], [57], [58]]. This dichotomy is reinforced by 
clinical imaging studies in cocaine addicts [53,59] and preclinical findings in cocaine self-administering rats that 
exhibit a progressive reduction in basal activity of putative pyramidal neurons in the mPFC but increased activity 
in response to cocaine- and cocaine-related cues [58]. Similarly, exposure to environmental cues linked 
morphine reward is strongly associated with distinct activity in select neuron populations in the PrLC [60], and 
reinstatement of heroin-seeking increases neuronal markers of activity such as c-fos and zif268 [[61], [62], [63]]. 
These observations suggest that PFC neurons may undergo unique forms of plasticity that permit them to 
exhibit a hypo- and hyperactive state following prolonged drug use (Fig. 1). in vitro electrophysiology studies in 
acute slices has shown that repeated, but not acute systemic cocaine exposure increases intrinsic membrane 
excitability in PrL, but not IL, deep layer pyramidal neurons that persists up to 45 days post drug exposure 
[[64], [65], [66], [67], [68]]. With more prolonged use, PrL pyramidal neurons show a reduction in intrinsic 
membrane excitability that is more pronounced in aversion-resistant rats thought to reflect compulsive 
behavior, and hat restoring this hypoexcitability using optical stimulation of pyramidal neurons alleviates 
uncontrolled cocaine intake [69]. Presently, no published findings on the effect of repeated opioid exposure 
on mPFC pyramidal neuron excitability exist, however reductions (cell non-specific) in the activity-regulated 
gene, c-fos, have been reported in the orbitofrontal cortex following a two-week chronic escalating-dose 
regimen of non-contingent morphine (Piao et al., 2017). Further, unpublished findings from our lab have 
recently observed that following a 14–21 d abstinence period from two weeks of daily remifentanil self-
administration, pyramidal neurons in the PrL show increased excitability and spike firing, and that these changes 
extend to the IL in a specific population of neurons (Anderson et al., unpublished observations). If the duration 
of self-administration is extended to 30–45 d, PrL neurons are less excitability (Anderson et al., unpublished 
observation) but exhibit an increased firing capacity at more depolarized potentials – adaptations that could 
significantly impact cortical information process and thus function. 
 
Fig. 1. Time- and sex-dependent adaptations in PFC pyramidal neuron physiology and underlying mechanisms. 
Data indicate that in males, short-term exposure to opiods increases the intrinsic excitability PrL pyramidal 
neurons, in part through a downregulation in metabotropic inhibitory signaling mediated by GABABR-Girk 
transmission (A–B). Following prolonged exposure, the activation threshold is increased (reduced excitability) in 
males – a phenomenon that occurs after only two weeks of self-administration in females (A–B). Hypoexcitable 
states appear to reflect reductions in synaptic AMPAR transmission as well as increased GABAA transmission and 
coincides with an increase in action potential frequency at more depolarized potentials (B) indicating that while 
these neurons are more difficult to initiate firing, once activated, mechanisms normally in place to restore firing 
to basal levels is impaired. Although the function implications are unclear, hypoactivation states may contribute 
to an impaired ability of the mPFC to exert inhibitory control, that may be further exacerbated by increased 
(disorganized) firing that disrupts cortical information processing or may contribute to the pathological 
strengthening of drug-seeking/taking behavior in response to drug-associated cues. 
 
2.2. Intrinsic and synaptic plasticity 
Studies to date have identified alterations in the expression and function of numerous voltage-gated and G 
protein-coupled ion channel conductance as contributing factors underlying increased excitability and neuronal 
firing following cocaine exposure, however almost nothing is known regarding intrinsic factors (non-synaptic 
factors) underlying opioid-induced changes in pyramidal neuron physiology 
[6,[64], [65], [66],[70], [71], [72], [73], [74], [75], [76], [77]]. Our preliminary findings suggest that similar to 
repeated cocaine, reductions in the threshold to fire following remifentanil self-administration align with 
reductions in metabotropic inhibitory signaling mediated by GABABR-dependent activation of G 
protein inwardly-rectifying potassium (Girk) channels in Layer 5/6 pyramidal neurons of the PrL region (Hearing 
et al., 2013; Anderson et al., unpublished observation). However, unlike cocaine, these effects are no longer 
present following 45 d abstinence – a temporal distinction that aligns with previous findings that incubating 
effects of cocaine on “craving” and drug-seeking persisted as long as 90 days, this phenomenon peaks at ∼12 d 
post returned to control levels by 60 d following heroin self-administration [[78], [79], [80], [81]]. 
A number of studies have also provided evidence for enduring changes in glutamate and GABA synaptic 
transmission following drug exposure. For example, cocaine increases mPFC expression of NMDA and AMPA 
receptor protein, while chronic alcohol upregulates postsynaptic NMDAR-mediated in layer 5/6 pyramidal cells – 
the latter of which was associated with elevations in spike-timing dependent plasticity [[82], [83], [84], [85]]. 
Although opioid-induced glutamate plasticity in the mPFC has been reported, the nature of these adaptations 
and their functional role in opioid addiction are less clear. Electrophysiology studies indicated that excitatory 
synaptic strength as measured by changes in the ratio of AMPA-to-NMDA receptor currents in pyramidal neuron 
is not altered following withdrawal from heroin self-administration (but see [86]), however this may reflect a 
lack of distinguishing neurons localized to the PrL versus IL and/or plasticity produced by 
extinction/reinstatement in this study [87]. Alternatively, this same study indicated that short-term glutamate 
plasticity (in the IL) in the form of AMPAR endocytosis plays a role in reinstatement of drug-seeking [87]. 
During early withdrawal from an intermediate period of cocaine self-administration, reductions in GABA 
transmission mediated by the ionotropic, GABAA receptor, appear to contribute to augmented induction of long-
term potentiation at PFC pyramidal neurons, however whether similar adaptations occur following opioid self-
administration is unclear [67,76]. These modifications, in conjunction with observed increases in excitability of 
mPFC pyramidal neurons, suggest that a shift in excitation at PFC output neurons may drive initial learning of 
drug seeking behavior as well as relapse during early opioid use. On the other hand, published work as well as 
our unpublished findings indicate that hypoexcitability of pyramidal neurons may instead reflect adaptations in 
synaptic GABAAR transmission rather than GABAB. In support of this, increased GABAergic inhibition of PrL 
pyramidal neurons has been shown to facilitate relapse to heroin-seeking [87], while increases in the frequency 
of IPSCs were found following remifentanil self-administration (Anderson et al., unpublished findings). 
Presently, almost nothing is known regarding how opioids alter plasticity in subpopulations of pyramidal 
neurons based on their anatomical connectivity and physiological phenotype. Effects of opioids on GABAergic 
interneurons have also not been directly measured, however recent optogenetic manipulation of parvalbumin-
expressing interneurons indicates that these neurons play a critical role in cognitive function [88,89] as well as 
extinction of reward seeking [90]. As cortical information processing and thus function relies on a balance of 
excitation:inhibition across multiple neuron types, identifying cell-specific modifications will be an important 
goal moving forward. 
2.3. Behavioral and clinical implications of PFC plasticity 
The functional implications of the co-occurring increased responsivity to drug-associated cues and reduced basal 
activation of the mPFC remains a vital question towards understanding how drugs of abuse impair cognitive 
control. One possibility is that during early drug use, increased excitability serves to lower the threshold for 
induction of long-lasting plasticity in PFC circuits (i.e., mPFC-to-NAc) important for learning drug seeking and 
drug taking behaviors or developing drug-cue associations responsible for precipitating craving and subsequent 
relapse. As drug-cues retain the ability to precipitate craving and activate the PFC, functionality of PrL circuits 
related to motivation and initiation of drug-seeking may be maintained, with reductions in basal metabolic 
activity serving to allow only drug-associated cues to ably activate PFC networks and thus maintain control over 
behavior [58,91]. 
Emergence of compulsive and uncontrollable opioid use likely reflects impaired function of the numerous frontal 
cortical regions as well as increasing activation of neural networks responsible for habit-like behavior 
[69,[92], [93], [94], [95], [96], [97]]. Clinical findings indicate that heroin addicts exhibit attention bias in drug-
associated contexts and often display increased impulsivity, cognitive inflexibility, and impaired attention [98,99] 
that are strong predictors of heroin abuse and relapse [[100], [101], [102]]. Although impulsivity and inflexibility 
are not synonymous with compulsivity or habit, impulsiveness – either intrinsic or drug-induced – appears to 
increase vulnerability toward compulsion and habit and may ultimately lead to substance abuse [4,103,104]. 
Moreover, perseverative responding despite its adverse consequences (cognitive inflexibility) is a significant 
predictor of poorer cocaine addiction treatment outcomes [105]. 
Preclinical studies in rodents have highlighted the PrL as a critical substrate for cognitive flexibility and attention 
[[106], [107], [108], [109], [110], [111], [112], [113]]. Recent findings showed reduced excitability of PrL 
pyramidal neurons in compulsive cocaine-seeking rats, which could be rescued by in vivo optogenetic 
stimulation of this region [69], thus the observed hypofunction of the PrL pyramidal neurons following 
remifentanil may contribute to perseverative drug-seeking. This is substantiated by impaired performance in 
mice exhibiting hypo-, but not hyperfrontal states (Anderson et al., unpublished observation). Alternatively, 
impulsive behavior appears to align more readily with altered functionality of the more ventral IL aspect of the 
mPFC as well as the OFC [114,115]. As our unpublished observations indicate that adaptations in IL pyramidal 
neuron excitability are likely pathway-specific, exploring how opioids alter ILC and OFC-associated circuits will 
likely provide additional insight into how frontal cortical dysfunction contributes to opioid abuse. 
Increasing evidence indicates that subpopulations of cortical pyramidal neurons exhibit distinctions in 
anatomical connectivity, molecular and physiological profile (i.e., expression of dopamine D1 vs. D2-receptors), 
and excitatory/inhibitory innervation that define how they undergo experience-induced plasticity and provide 
an anatomical frame work to regulate complex behavior related to cognitive control and reward [21,22,27,28]. 
Given this framework, it is plausible specific PFC circuits are activated by opioids and associated stimuli, whereas 
concomitant impairments in other circuits – perhaps those exhibiting hypoactivation – contribute to opioid-
related deficits in cognitive control and perpetuate a shift in the balance of behavioral control to more dorsal 
striatal (i.e., habit) circuits following cue activation 
3. Nucleus accumbens 
The NAc is a heterogenous structure that can be divided into a core and shell region based on anatomical 
connectivity and presumptive role in reward-related behavior [[116], [117], [118], [119], [120], [121], [122]]. 
GABAergic medium-spiny neurons (MSNs) make up a majority of all neurons in the NAc and receive coordinated 
input from glutamatergic afferents arising from cortical and limbic brain regions that elicit physiological and 
behavioral responses [[123], [124], [125], [126]]. Canonically divided into two main subpopulations based on D1- 
or D2-type dopamine receptor expression and efferent regulation of basal ganglia output structures 
[[127], [128], [129], [130], [131], [132]], these two subtypes display unique intrinsic physiology, differentially 
undergo drug-induced plasticity, and play dissociable (often opposing) roles in drug-reward-related behavior 
[126,[133], [134], [135], [136], [137], [138]]. 
3.1. Intrinsic MSN physiology 
Activity of NAc MSNs is dependent on synaptic input as well as intrinsic membrane properties that directly 
influence the probability and pattern of neuronal firing (i.e. excitability). These intrinsic properties are 
dependent on factors extrinsic to the synapse, such as expression and function of voltage-gated and G protein-
coupled channels and are known to be altered by drugs of abuse [6,[70], [71], [72], [73], [74], [75]], but often 
take a backseat to research focusing on adaptations in transmission mediated by synaptic receptors. 
At present, relatively little is known regarding the effect of opioids on intrinsic physiology. Following 10 d of 
abstinence from repeated non-contingent morphine increase firing capacity of MSNs [74,75]. While these 
studies did not identify MSN subpopulations based on dopamine receptor expression, morphine plasticity was 
examined based on membrane properties, i.e., the intrinsic excitability and spike adaptation. Morphine 
increased the initial firing frequency and decreased the train duration in “type I” MSNs that show high levels of 
intrinsic excitability basally, without altering action potential threshold (rheobase). Alternatively, morphine 
reduced rheobase (increased excitability) of “type II” MSNs, without altering firing frequency or train duration 
[74]. In contrast to the shell, repeated morphine suppressed excitability in unidentified NAc core MSNs [71]. 
Although the exact mechanisms underlying morphine adaptations based on neuron sub-type are unclear, 
increases in NAc shell MSN excitability is due in part to increased activation of extrasynaptic NMDA 
receptors which in turn inhibits sustained voltage-gated potassium currents, reduced excitability in the core 
aligns with upregulation of inwardly-rectifying potassium channels [71,74,139]. 
Interpreting the relevance of changes in the NAc core versus shell is challenging given how little is known about 
how the overall MSN firing is affected by the interplay between excitatory synaptic inputs projecting to MSNs 
(which are enhanced following long-term withdrawal of both cocaine or morphine) and MSN intrinsic 
excitability. Furthermore, it is unclear how alterations in MSN intrinsic activity and their inhibitory regulation of 
projection sites during long-term withdrawal regulate drug-seeking behaviors. Reduced intrinsic excitability of 
MSNs likely leaves these neurons less responsive to activation by excitatory drive, whereby only 
increased glutamate release driven by exposure to drug-related stimuli is sufficient to overcome this dampening 
of activity – thus increasing signal-to-noise ratio for drug-associated stimuli and reducing it for other stimuli 
[140]. 
Notably, intrinsic changes following morphine exposure also appear to directly contrast psychostimulant-
induced adaptations. For example, in the shell, repeated non-contingent cocaine or amphetamine exposure 
increased various K + currents while decreasing background Na + and voltage-gated Ca2+ currents mediated by 
N- and R-type channels in unidentified MSNs that translated into suppression of MSN firing capacity in acute 
brain slices 1–21 d following the final drug exposure [73,[141], [142], [143]]. MSNs in the NAc core on the other 
hand exhibit increased excitability during acute psychostimulant withdrawal, that unlike the shell, returns to 
control levels by day 10 of withdrawal [73]. The drug-specific discrepancies on MSN intrinsic excitability are 
intriguing to say the least. Particularly difficult to interpret are the opposing effects in the NAc core given its role 
in the in the motor activating effects of abused drugs, and that cocaine and morphine doses used in these 
experiments both produce prominent behavioral sensitization. However, these results appear to align with in 
vivo studies have previously shown differential responses in single-unit recordings during cocaine and heroin 
self-administration [144]. Future work using transgenic mice will be of value to address critical questions, 
including how these properties align based on the expression of D1 or D2Rs and how changes in excitability 
contribute to regulation of drug-seeking behavior. 
3.2. Opioid reward and relapse-related glutamate plasticity 
Ample evidence has shown that glutamate transmission at NAc MSNs contributes to opioid reward, withdrawal, 
and relapse [8,9,39,40,43,108,139,[145], [146], [147], [148], [149], [150], [151], [152]]. However neuronal 
“interpretation” of this glutamate release is complex, as it depends on the afferent, MSN subtype (i.e., D1- vs. 
D2-MSN), and efferent connectivity (i.e., VP or SN) [130,[153], [154], [155], [156]]. This complexity combined 
with the fact that drug-induced modifications in NAc glutamate transmission often involve a postsynaptic 
receptor number and/or conductance [157], presynaptic release mechanisms, and glutamate clearance 
mechanisms, represents a major challenge towards identifying the nature and locus of opioid-induced plasticity 
and how specific neural circuit modifications uniquely contribute to aspects of opioid addiction (dependence 
versus relapse). Below we will highlight what is known regarding changes in glutamate plasticity within the NAc 
at both the pre- and postsynaptic level and what circuits these modifications manifest. 
AMPA- and NMDA-type ionotropic glutamate receptors are the primary mediators of rapid glutamate 
transmission and exert a profound influence on synaptic plasticity and cellular physiology [158]. Changes in the 
conductance, expression, and localization (e.g., synaptic vs. perisynaptic) of these receptors plays a key role in 
drug-induced and experience-related plasticity -- making these receptors a key target for studying how opioids 
promote persistent addicted behavior and development of future pharmacotherapies. Recent 
electrophysiological findings indicate that repeated non-contingent morphine increases excitatory drive at NAc 
shell D1-MSNs, while reduced it at D2-MSNs. The increase in synaptic strength reflects upregulation of AMPA-
type receptor signaling through insertion of GluA2-lacking calcium permeable AMPARs as well as enhanced 
glutamate release probability [75,134,135]. Alternatively, weakened D2-MSN signaling reflects a reduction in 
presynaptic release and a time-dependent loss of AMPAR expression and dendritic spines [134,135]. Similar to 
cocaine this augmented synaptic strength is not immediately present, as no changes in glutamate 
receptor signaling were observed 12 h following the final exposure – highlighting a need for time to develop 
[[134], [135], [136],149]. 
Unlike cocaine, increases in synaptic strength did not extend to MSNs in the NAc core [134], however recent 
unpublished observations indicate that AMPAR transmission (mEPSC frequency and amplitude) is increased at 
D1-MSNs in the core and shell following 10–14 d of withdrawal from remifentanil self-administration (Madayag 
et al., unpublished observations). 
3.3. Dependence/Withdrawal glutamate plasticity 
The enduring nature of adaptations within the mPFC-NAc pathway indicate that these changes likely contribute 
to strengthening of drug-seeking behavior and subsequent relapse in response drug-associated stimuli (Fig. 2, 
top). However, evidence indicates that upregulation of NAc AMPAR signaling also plays a critical role in the 
development of dependence and expression of withdrawal symptoms. For example, chronic morphine exposure 
elevated GluA2-lacking AMPAR surface expression in the NAc and intra-shell infusion of a GluA2-lacking selective 
antagonist blocked naloxone-precipitated affective, but not somatic, withdrawal [152] [152]. Electrophysiology 
studies following repeated systemic morphine indicate that this upregulation may occur selectively at PVT-to-
NAc shell D2-MSN synapses, and contributes to establishing withdrawal-related aversive memories [159]. Given 
that morphine withdrawal increases extracellular glutamate levels in the NAc (Sepulveda et al., 1998) and 
appears to increase release probability at D1- and D2-MSNs (pooled afferents) (Madayag et al., unpublished 
observation), it is possible that upregulation of excitatory signaling at D1-MSNs contribute to conditioned 
reward and relapse similar to those observed following intermittent non-contingent morphine [134,135] 
whereas “priming” of D2-MSNs via increased AMPAR receptor activation is responsible for withdrawal-related 
symptoms, with specific pathways contributing to unique aspects of this withdrawal (i.e., negative affect vs. 
somatic; Fig. 2, bottom) that may lead individuals to increase use in attempt to mitigate these negative 
symptoms. 
 
Fig. 2. Proposed role of known opioid adaptations in nucleus accumbens glutamate transmission in opioid 
addiction. Repeated exposure to opioids promotes a number of pre- and postsynaptic modifications in 
excitatory currents, most of which appears to be mediated by the ionotropic AMPA-type 
receptors. (Top) Enduring adaptations at mPFC-to-NAc synapses aligning with plasticity associated with 
establishing learned drug associations, drug-seeking/taking behavior, and relapse. Modifications include 
increased glutamate release probability and insertion of AMPARs that are permeable (GluA1/GluA1; blue-blue) 
or impermeable (GluA1/GluA2; blue-green) at PrL-to-Core (light blue) and IL-to-Shell (dark blue) synapses on D1-
MSNs (red) as well as reduced excitatory drive and increased synapse numbers in D2-MSNs (green). These cell-
specific adaptations promote an overall shift in excitatory drive within D1- and D2-MSN circuits that favors 
strengthening of D1-MSN pathways. (Bottom) The cellular, temporal, and mechanistic nuances of NAc 
glutamate plasticity contributing to dependence and withdrawal are less clear. Morphine withdrawal is 
associated with increased extracellular glutamate, which may reflect increased release probability or impaired 
clearance, or both. It is possible that upregulation of excitatory signaling plays distinct roles depending on the 
MSN sub-type, with increased signaling at D1-MSNs reflecting changes related to reward/relapse whereas 
signaling at D2-MSNs is responsible for withdrawal-related symptoms, with specific pathways contributing to 
unique aspects of this withdrawal (i.e., negative affect vs. somatic). (For interpretation of the references to 
colour in this figure legend, the reader is referred to the web version of this article). 
 
3.4. Pathway-specific plasticity 
Increasing evidence indicates that the nature and locus of opioid-induced plasticity in the NAc indicates that this 
plasticity dictates the relationship to behavior. Initial examination of plasticity within mPFC-to-NAc circuits using 
optogenetics has shown that IL-to-Shell synapses are strengthened by increased insertion of GluA2-lacking 
receptors selectively at D1R-MSN synapses following 10–14 withdrawal from repeated non-contingent 
morphine exposure [99]. Preliminary findings from our lab have shown that similar adaptations occur at D1-MSN 
IL-to-Shell synapses following abstinence from remifentanil self-administration (Madayag et al., unpublished 
observations). While the functional implications of this plasticity following opioid self-administration are unclear, 
our previous work has shown that reversal of morphine-induced pathophysiology using in vivo optogenetic 
stimulation (10 Hz) of IL-to-Shell inputs disrupts reinstatement of morphine-evoked conditioned place 
preference [134]. Information regarding adaptations within the PrL-to-Core pathway is essentially non-existent, 
however recent examination of this pathway following remifentanil self-administration showed an increased 
presence of synaptic GluA2-lacking AMPAR and release probability at D1-MSNs and reduced excitatory drive at 
D2-MSNs, the latter of which may reflect adaptations in at the post and presynaptic level (Madayag et al., 
unpublished observation). 
It is tempting to speculate that the emergence of plasticity in the more motor-centric core region of the NAc 
reflects the use of an operant- and goal-directed based model of opioid self-administration, as non-contingent 
exposure did not alter AMPAR transmission (or release probability) following non-contingent morphine, 
however it is also possible that enduring plasticity in the NAc core is primarily expressed at synapses receiving 
significant innervation from PrL afferents [134]. Regardless, the functional role of this plasticity requires further 
exploration, as work to date has primarily highlighted a role for the IL-to-Shell pathway in opioid relapse 
[39,40,148,151,160]. Based on previous circuit lesion studies [39,40,148,160] it is possible that plasticity within 
the PrL-Core circuit is responsible for maintaining drug- and drug-cue associations responsible for driving 
relapse-related behavior, whereas context-based drug-associations are retained by plasticity in the IL-Shell 
circuit and that these adaptations work in concert to maintain relapse vulnerability. 
Examination of circuit plasticity outside of cortico-accumbens circuits indicates that glutamate release 
probability is elevated at BLA- but not PrL-to-Core MSNs as early as 2 h following an escalating regimen of 
morphine over 5 days [161]. Alternatively, while release probability is unchanged at BLA- and PVT-to-Shell MSNs 
within the first 24 h of repeated non-contingent morphine, there is an upregulation of GluA2-lacking AMPARs at 
PVT-to-Shell inputs selectively on D2-MSN that when reversed suppressed somatic withdrawal and aversive 
memories [159]. Taken together, these data highlight an intriguing possibility that enhanced transmission at 
thalamic transmission at D2-MSNs promote dependence/withdrawal-related negative affective states that drive 
continued use, whereas developing adaptations within PFC-to-NAc circuits that produce a shift in the ratio 
between excitatory synaptic drive at D1R- over D2R-MSN synapses represent enduring pathophysiology that 
drives relapse. Regardless, these data highlight a need to better understand the temporal, state-dependent, and 
cell-specific dynamics of opioid-induced pre- and postsynaptic plasticity, as it will provide better insight into how 
each may contribute to unique aspects of behavior (i.e., reward and relapse versus dependence and 
withdrawal). 
3.5. Intrinsic and extrinsic factors influencing opioid abuse 
A wealth of clinical data indicates that environmental and genetic factors contribute to an individuals 
susceptibility to addiction. Although outside the scope of this review (see Mistry et al., 2014 for a review), 
heritability of opioid abuse has been linked into part to polymorphisms in the genes encoding for dopamine d2 
receptors, mu and delta opioid receptors, as well as neurotrophic and growth-related factors such as BDNF and 
NGF (Mistry et al., 2014). Although the co-occurrence of prolonged environmental and psychological stressors 
has also been linked to increased risk for opioid abuse, a critical unresolved question is how stress influences 
opioid use and what specific opioid- and stress-induced adaptations in cellular physiology and synaptic plasticity 
lead to these maladaptive behaviors. Moreover sex differences in drug use and stress responsivity is evident in 
humans and animal models, however a vast majority of work continues to focus primarily on males -- leaving 
major gaps regarding the influence of sex on drug- and stress-induced neural plasticity and behavior 
[[162], [163], [164]]. In susceptible populations, women escalate cocaine use more rapidly and show a greater 
tendency to relapse and experience a loss of voluntary control of intake [165,166]. 
Despite a 100% increase in the number of women using heroin in recent years [167,168], data on sex differences 
in opioid use are relatively lacking. Human studies have shown that women report greater craving and exhibit 
increased vulnerability to relapse than men [168,169], however the underlying mechanism for this sex 
difference are unknown. Our preliminary findings indicate that hypoexcitability states in mPFC pyramidal 
neurons emerges following only 14 d of self-administration and that these changes may have significant 
implications for cognitive function and relapse. An important unanswered question is whether this reflects a 
leftward temporal shift whereby females exhibit hyperexcitability following a shorter period of drug 
administration (e.g., 5 days), or if this shift occurs due to intrinsic differences in pyramidal excitability (Fig. 1A) 
across sexes [170]. Moreover, it remains unclear whether hypofrontal states reflect a shift in the corticostriatal 
circuits driving behavior, such as those regulating habit behavior, or if mPFC-NAc circuits are still required for 
initiation of this behavior. 
Although difficult to causally disentangle multiple variables, identifying the locus, and temporal dynamics of 
corticostriatal plasticity produced by opioids and stress as well as relevant sex-specific and genetic-based 
differences that contribute to this plasticity and impact later opioid use in susceptible populations, will advance 
our understanding of how these modifications uniquely contribute to behavioral deficits in addiction and 
neuropsychiatric disease and aide development of more targeted and impactful therapies to treat opioid use 
disorders. 
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